Cargando…

Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines

The POSEIDON (Patient-Oriented Strategies Encompassing IndividualizeD Oocyte Number) criteria were developed to help clinicians identify and classify low-prognosis patients undergoing assisted reproductive technology (ART) and provide guidance for possible therapeutic strategies to overcome infertil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esteves, Sandro C., Conforti, Alessandro, Sunkara, Sesh K., Carbone, Luigi, Picarelli, Silvia, Vaiarelli, Alberto, Cimadomo, Danilo, Rienzi, Laura, Ubaldi, Filippo Maria, Zullo, Fulvio, Andersen, Claus Yding, Orvieto, Raoul, Humaidan, Peter, Alviggi, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017440/ https://www.ncbi.nlm.nih.gov/pubmed/33815269 http://dx.doi.org/10.3389/fendo.2021.587051

Ejemplares similares

The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists
por: Esteves, Sandro C., et al.
Publicado: (2019)

Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials
por: Conforti, Alessandro, et al.
Publicado: (2021)

Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW
por: Esteves, Sandro C., et al.
Publicado: (2021)

Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria—The Why
por: Esteves, Sandro C., et al.
Publicado: (2018)

Management of Women With an Unexpected Low Ovarian Response to Gonadotropin
por: Conforti, Alessandro, et al.
Publicado: (2019)

DuoStim – a reproducible strategy to obtain more oocytes and competent embryos in a short time-frame aimed at fertility preservation and IVF purposes. A systematic review
por: Vaiarelli, Alberto, et al.
Publicado: (2020)

Management Strategies for POSEIDON Group 2
por: Sunkara, Sesh Kamal, et al.
Publicado: (2020)

Impact of Maternal Age on Oocyte and Embryo Competence
por: Cimadomo, Danilo, et al.
Publicado: (2018)

Management Strategies for POSEIDON Groups 3 and 4
por: Haahr, Thor, et al.
Publicado: (2019)

Future Perspectives of POSEIDON Stratification for Clinical Practice and Research
por: Humaidan, Peter, et al.
Publicado: (2019)

The Impact of Unbalanced Maternal Nutritional Intakes on Oocyte Mitochondrial Activity: Implications for Reproductive Function
por: Fabozzi, Gemma, et al.
Publicado: (2021)

Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept
por: Drakopoulos, Panagiotis, et al.
Publicado: (2020)

Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle
por: Cimadomo, Danilo, et al.
Publicado: (2018)

The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome
por: Humaidan, Peter, et al.
Publicado: (2016)

Pharmacogenetics of FSH Action in the Female
por: Conforti, Alessandro, et al.
Publicado: (2019)

Validation of ART Calculator for Predicting the Number of Metaphase II Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection
por: Esteves, Sandro C., et al.
Publicado: (2020)

The POSEIDON stratification - moving from poor ovarian response to low prognosis
por: Roque, Matheus, et al.
Publicado: (2021)

Severe male factor in in vitro fertilization: definition, prevalence, and treatment. An update
por: Mazzilli, Rossella, et al.
Publicado: (2021)

Male factor infertility and assisted reproductive technologies: indications, minimum access criteria and outcomes
por: Mazzilli, R., et al.
Publicado: (2023)

Personalized Nutrition in the Management of Female Infertility: New Insights on Chronic Low-Grade Inflammation
por: Fabozzi, Gemma, et al.
Publicado: (2022)

Pre-implantation genetic testing in ART: who will benefit and what is the evidence?
por: Vaiarelli, Alberto, et al.
Publicado: (2016)

Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment
por: Ubaldi, Filippo Maria, et al.
Publicado: (2019)

Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis
por: Vaiarelli, Alberto, et al.
Publicado: (2018)

COVID-19 and assisted reproductive technology services: repercussions for patients and proposal for individualized clinical management
por: Alviggi, Carlo, et al.
Publicado: (2020)

Reduction of multiple pregnancies in the advanced maternal age population after implementation of an elective single embryo transfer policy coupled with enhanced embryo selection: pre- and post-intervention study
por: Ubaldi, Filippo Maria, et al.
Publicado: (2015)

Management of Poor Responders in IVF: Is There Anything New?
por: Ubaldi, Filippo, et al.
Publicado: (2014)

Clinical and laboratory key performance indicators in IVF: A consensus between the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) and the Italian Society of Embryology, Reproduction and Research (SIERR)
por: Vaiarelli, Alberto, et al.
Publicado: (2023)

The Impact of Biopsy on Human Embryo Developmental Potential during Preimplantation Genetic Diagnosis
por: Cimadomo, Danilo, et al.
Publicado: (2016)

Multi- and Transgenerational Effects of Environmental Toxicants on Mammalian Reproduction
por: Rebuzzini, Paola, et al.
Publicado: (2022)

COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine
por: Vaiarelli, Alberto, et al.
Publicado: (2020)

Innovative Strategies for Fertility Preservation in Female Cancer Survivors: New Hope from Artificial Ovary Construction and Stem Cell-Derived Neo-Folliculogenesis
por: Canosa, Stefano, et al.
Publicado: (2023)

Understanding Follicular Output Rate (FORT) and its Implications for POSEIDON Criteria
por: Grynberg, Michael, et al.
Publicado: (2019)

Reply: The low responder according to the POSEIDON criteria: is the prognosis really poor?
por: Leijdekkers, Jori A, et al.
Publicado: (2019)

Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria
por: Liu, Xueying, et al.
Publicado: (2021)

Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients
por: Esteves, Sandro C, et al.
Publicado: (2021)

Cumulative Live Birth Rates in Low Prognosis Patients According to the POSEIDON Criteria: An Analysis of 26,697 Cycles of in vitro Fertilization/Intracytoplasmic Sperm Injection
por: Li, Yuan, et al.
Publicado: (2019)

Comparison of ART outcome in patients with poor ovarian response according to POSEIDON criteria
por: Lee, Hyun Joo, et al.
Publicado: (2022)

Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus
por: Orvieto, Raoul, et al.
Publicado: (2021)

Efficacies of different ovarian hyperstimulation protocols in poor ovarian responders classified by the POSEIDON criteria
por: Li, Fei, et al.
Publicado: (2020)

The first mitotic division: a perilous bridge connecting the zygote and the early embryo
por: Coticchio, Giovanni, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_em4t1ni75lef977pemnafucpvs